关注
Parker Sulkowski
Parker Sulkowski
在 pfizer.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
PL Sulkowski, CD Corso, ND Robinson, SE Scanlon, KR Purshouse, ...
Science translational medicine 9 (375), eaal2463, 2017
5242017
Oncometabolites suppress DNA repair by disrupting local chromatin signalling
PL Sulkowski, S Oeck, J Dow, NG Economos, L Mirfakhraie, Y Liu, ...
Nature 582 (7813), 586-591, 2020
2412020
Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair
PL Sulkowski, RK Sundaram, S Oeck, CD Corso, Y Liu, S Noorbakhsh, ...
Nature genetics 50 (8), 1086-1092, 2018
1902018
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery
R Bahal, N Ali McNeer, E Quijano, Y Liu, P Sulkowski, A Turchick, YC Lu, ...
Nature communications 7 (1), 13304, 2016
1612016
Mitochondrial DNA stress signalling protects the nuclear genome
Z Wu, S Oeck, AP West, KC Mangalhara, AG Sainz, LE Newman, ...
Nature metabolism 1 (12), 1209-1218, 2019
1052019
Mcp1 promotes macrophage-dependent cyst expansion in autosomal dominant polycystic kidney disease
MF Cassini, VR Kakade, E Kurtz, P Sulkowski, P Glazer, R Torres, ...
Journal of the American Society of Nephrology 29 (10), 2471-2481, 2018
992018
Nickel induces transcriptional down-regulation of DNA repair pathways in tumorigenic and non-tumorigenic lung cells
SE Scanlon, CD Scanlon, DC Hegan, PL Sulkowski, PM Glazer
Carcinogenesis 38 (6), 627-637, 2017
482017
miR-155 overexpression promotes genomic instability by reducing high-fidelity polymerase delta expression and activating error-prone DSB repair
JR Czochor, P Sulkowski, PM Glazer
Molecular Cancer Research 14 (4), 363-373, 2016
482016
PTEN regulates nonhomologous end joining by epigenetic induction of NHEJ1/XLF
PL Sulkowski, SE Scanlon, S Oeck, PM Glazer
Molecular Cancer Research 16 (8), 1241-1254, 2018
252018
Suppression of homology-dependent DNA double-strand break repair induces PARP inhibitor sensitivity in VHL-deficient human renal cell carcinoma
SE Scanlon, DC Hegan, PL Sulkowski, PM Glazer
Oncotarget 9 (4), 4647, 2018
252018
LINE-1 activation in the cerebellum drives ataxia
T Takahashi, M Stoiljkovic, E Song, XB Gao, Y Yasumoto, E Kudo, ...
Neuron 110 (20), 3278-3287. e8, 2022
182022
Abstract LB-029: Negative transcriptional and epigenetic regulation of DNA repair pathways by the heavy metals nickel and arsenic
SE Scanlon, CD Scanlon, DC Hegan, P Sulkowski, PM Glazer
Cancer Research 76 (14_Supplement), LB-029-LB-029, 2016
22016
Response to: Elevated L1 expression in ataxia telangiectasia likely explained by an RNA-seq batch effect
T Takahashi, M Stoiljkovic, E Song, XB Gao, Y Yasumoto, E Kudo, ...
Neuron 111 (5), 612-613, 2023
12023
Nanoparticle-Mediated Correction of the Sickle Cell Mutation
E Quijano, R Bahal, Y Liu, A Gupta, S Oyaghire, AS Ricciardi, HK Mandl, ...
MOLECULAR THERAPY 27 (4), 278-278, 2019
12019
Compositions and methods for targeting cancers
R Bindra, P Glazer, P Sulkowski, B Shuch
US Patent 11,311,538, 2022
2022
Oncometabolites suppress homologous recombination DNA repair by inhibition of chromatin remodeling at the DNA double-strand break
PS Sulkowski, S Oeck, J Li, B Shuch, MC King, RS Bindra, PM Glazer
CANCER RESEARCH 79 (13), 2019
2019
Abstract SY21-02: Oncometabolites suppress homologous recombination DNA repair by inhibition of chromatin remodeling at the DNA double-strand break
PS Sulkowski, S Oeck, J Li, B Shuch, MC King, RS Bindra, PM Glazer
Cancer Research 79 (13_Supplement), SY21-02-SY21-02, 2019
2019
Compositions and methods for targeting and treating homologous recombination-deficient tumors
R Bindra, P Glazer, N Robinson, P Sulkowski, C Corso
US Patent App. 16/306,215, 2019
2019
Production of 2-Hydroxyglutarate by IDH Mutant Malignancies Induces a BRCAness State That Can be Exploited By PARP Inhibitors and Radiation
CD Corso, RS Bindra, PM Glazer, PL Sulkowski, ND Robinson, ...
International Journal of Radiation Oncology, Biology, Physics 99 (2), E68, 2017
2017
Abstract LB-290: Oncometabolites induce a BRCAness state that can be exploited by PARP inhibitors
P Sulkowski, C Corso, N Robinson, S Scanlon, K Purshouse, H Bai, Y Liu, ...
Cancer Research 77 (13_Supplement), LB-290-LB-290, 2017
2017
系统目前无法执行此操作,请稍后再试。
文章 1–20